In the wake of the COVID pandemic, consumers have become painfully aware of America’s heavy dependence on imports. The recent Amoxicillin shortage in hospitals has made this particularly clear since the United States is now highly reliant on imported antibiotics and other lifesaving medications. The United States is so deep in the hole when it…
Last year, more than 73,000 Americans died from an overdose of the synthetic opioid fentanyl. The drug itself is cheap and readily available, with thousands of pounds flowing into the United States from Mexico every month. In fact, fentanyl seizures at the U.S.-Mexico border increased 164 percent between 2020 and 2022 alone. Even more disturbing is that Americans can now have…
Senators Demand Clarity On Imports In New Bill, Seeking Consumer Protection & Better Trade Rules Enforcement
Manifest Modernization Act would require companies like FedEx and DHL, which import goods into the U.S., to follow same rules as ocean shipping companies. The bill was written by Sens. Cassidy and Whitehouse.
The leaders of the Senate Energy and Natural Resources Committee grilled a government official on the EV batteries supply chain. From copper to EV battery minerals, the U.S. is way behind.
Dan Harris, international lawyer at Harris Bricken and founding author of the China Law Blog talks about companies leaving China. Are any coming here?
Companies are leaving China for Southeast Asia, but in many cases, that doesn’t mean they have stopped doing business with the same Chinese company.
The U.S. China Economic & Security Review Commission heard from witnesses about keeping auto tariffs on China, and more incentives for manufacturing to reshore.
Don’t blame the China tariffs on inflation. Supply chain snafus were a much bigger deal, a Federal Reserve report says.
At National Press Club, Katherine Tai talks about supply chain issues, what ‘de-risking’ from China might look like, and how USTR thinks about it.
A Chinese cancer drug maker that has not been inspected by the FDA since 2018 is selling chemotherapy drugs to the U.S. due to shortages. When will the U.S. meet its critical medication needs?